Spotlighting Miracle: How USA Olympic Archer Turned Founder Jin Kim Is Accelerating Clinical Trials

Biotech is one of the hardest industries to break into...regulated, slow, compliance-heavy, and notoriously resistant to new software. Yet Jin Kim, a solo YC founder, is doing what few believed possible: building a profitable, fast-growing AI platform that transforms how biotech companies run clinical trials.